Detection methods employing HCV core lipid and DNA binding domain monoclonal antibodies
US10345311B2 · kind B2 · utility
0Cited by
116References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 22, 2016 |
| Grant date | Jul 9, 2019 |
| Priority date | — |
| Expiry date | Sep 23, 2036 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/52
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
The present disclosure provides detection methods employing HCV core lipid binding domain and DNA binding domain monoclonal antibodies. In certain embodiments, the lipid binding domain monoclonal antibody recognizes an epitope in amino acids 141 to 161 of HCV core protein.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.